InvestorsHub Logo
icon url

Gold Seeker

11/05/10 5:51 PM

#27581 RE: bestvaluestocks #27578

Great Grandma, Opportunity needs to relax a bit.

First of all, there is nothing about RECAF that can be patented. The receptor is in public domain and can be used by anyone. Others are already using synthetic peptides and undoubtedly already have patents for cancer cell delivery.

It may be very difficult for Moro to get his patent approved.

http://www.nytimes.com/2010/08/24/health/24drug.html

How are the guys above getting their drug delivered to the cell via the synthetic peptide. Is it passing through via RECAF?